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Efforts to engage the public in science take
many forms, yet in many cases, ‘‘engage-
ment’’ is a means toward acceptance rather
than true participation. In 2008, the largest
ever public engagement (PE) exercise spon-
sored by UK Research Councils was held.
The Stem Cell Dialogue (SCD), designed to
identify the range of views and concerns
amongst the wider public about stem cell
research, was jointly supported by the
Biotechnology and Biological Sciences Re-
search Council (BBSRC), the Medical Re-
search Council (MRC), and Sciencewise.
The SCD revealed high levels of public
support for stem cell science and technology,
according to the official press release [1], and
thus seems to validate the traditional reasons
offered for conducting PE around cutting-
edge science: that engaging the wider public
in dialogue at an early stage can help
scientists communicate the motivations for
their research, including its expected societal
benefits, assuage potential ethical concerns,
avert damaging controversies, and secure
public acceptance. But, is this instrumental
rationale—engagement toward a predeter-
mined goal—sufficient? Can it offer the
democratic legitimacy that underlies the
recent turn to this type of ‘‘upstream’’
engagement? And does the SCD as it actually
unfoldedmerit the summary finding of public
support reported in the press release? In this
paper, we draw from our work as official
evaluators of the SCD (see Box 1), and recent
debates on the purpose of engagement, to
ask: how should we understand the ‘‘public’’
in PE; why is PE important for both society
and science; and what lessons should we take
from actual PE exercises?
Which ‘‘Public’’ and What
‘‘Engagement’’?
How the ‘‘public’’ is defined in various
initiatives depends on the rationale for
asking for public input. This in turn affects
how members of the public are brought
together and represented.
Previous articles in this series [2,3] have
identified three rationales for PE [4] and
have critiqued the most common instru-
mental rationale to enhance public trust in
novel areas of science and acceptance of
the future technologies or to legitimise
research policy decisions. The value of
public dialogue in a democratic society is
twofold. From a normative perspective, the
process of PE is in itself a good thing in
that the public should be consulted on
decisions in which they have a stake. From
a substantive standpoint, PE generates
manifold perspectives, visions, and values
that are relevant to the science and
technologies in question, and could poten-
tially lead to more socially robust out-
comes (which may differ from the out-
comes envisaged by sponsors or scientists).
Yet in any PE exercise, challenges arise
not just in bringing people together, but
also in facilitating interactions to ensure
that different perspectives are elicited and
considered and that the outcome provides
a legitimate picture of public dialogue. For
PE around bioscience developments to
conform to democratic ideals, it has been
asserted, participants must be broadly re-
presentative of the ‘‘affected public’’ [5].
This concept of representativeness forms a
key normative criterion of a widely used
framework for evaluating PE effectiveness
[5]. Representativeness refers to the de-
gree to which participants embody the
socio-demographic characteristics of the
affected population, including the relative
distribution of views. However, represen-
tativeness of participation—that is, the
diversity of opinions expressed—may not
necessarily translate to representativeness
in the end. In practice, a diversity of
outcomes is often inhibited by the partic-
ular method, process, and reporting of
engagement, which thus may lead to
failure in democratic terms.
In the translation from theory to prac-
tice, rationales for PE (explicit or implicit)
may change or become blurred, undercut-
ting transparency or legitimacy [6]. Such
changes can lead to tensions in the practice
of PE that may affect the ways in which the
‘‘representativeness’’ of the public is con-
strued. These rationales provide a useful
framework for thinking about just how
representative a given public may be under
different scenarios. The SCD illustrates
how competing rationales for representing
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the public can lead to particular outcomes
that conflict with the democratic ideals of
PE.
Stem Cell Dialogue
An oversight sroup comprised of 19
members representing a broad range of
interests relating to stem cell research—
including from universities, charities, and
public interest groups—commissioned the
British Market Research Bureau (BMRB)
to deliver the UK-wide public dialogue.
BMRB developed a deliberative process
that brought together members of the
public with scientists, clinicians, social
scientists, and ethicists. A total of 15
workshops—three each in London, Bris-
tol, Cardiff, Edinburgh, and Newcastle—
were held, beginning with an introduction
to stem cells and moving on to discussions
of social and ethical issues around sourcing
of stem cells, potential future applications,
clinical trials, and stem cell banks.
The sponsors’ official aims and objec-
tives embodied both a normative commit-
ment to ‘‘engage the diverse public about
developments in stem cell research, to
account for their views in policy develop-
ment’’ and a substantive aspiration to
‘‘identify the range of views and concerns
about the science and ethics of stem cell
research amongst the wider public and
their societal context’’ (authors’ emphasis).
Yet the twin goals of diversity of partici-
pation and perspectives failed to translate,
in practice, into diversity of outcomes—
the officially reported outcome being high
levels of public support for stem cell
science and technology. Even BMRB’s
own report had noted this result, though
the document downplayed it by outlining
various ways in which support is condi-
tional.
The research and policy background to
the SCD suggests a preconceived outcome
for the dialogue. The SCD emerged out of
a recommendation of the UK Stem Cell
Initiative (UKSCI) to take into account
public attitudes by engaging the UK
public in a dialogue on the ethical issues
surrounding the sources and uses of
embryonic stem cell lines, the use of
animal experimentation, and the benefits
and risks of stem cell therapies [7]. The
UKSCI’s terms of reference express a
clear mandate for stem cell research that
involves developing a 10-year vision for
UK stem cell research that seeks to make
the UK the most scientifically and com-
mercially productive location for this
activity over the coming decade. The
public dialogue also coincided with the
Commons debate of the Human Fertilisa-
tion and Embryology Bill that provides for
revised and updated legislation on assisted
reproduction and for changes to the
regulation and licensing of embryo use in
research and therapy. In this context,
the consensual outcome of ‘‘high levels of
public support’’ potentially evokes pres-
sures to achieve legitimacy for, and trust
in, policy commitments in process or
already decided.
Against this background, competing
rationales for representing the public
infused the SCD’s methodology, process,
and reporting. The SCD employed a
statistical approach to obtain a represen-
tative sample of public views. Two hun-
dred participants were recruited according
to the demographic profile of the work-
shop locations to reflect quotas set for age,
socioeconomic status, and ethnicity. Atti-
tudes about stem cells were also screened
to ensure the sample was broadly repre-
sentative of public attitudes profiled in the
results of a BMRB UK-wide omnibus
survey (n=1,000) which reported that
73% approved of stem cell research and
76% approved of the use of embryos in
such research. Although ‘‘testing’’ the
representativeness of participants’ attitudes
is a standard method [8,9], it aggregates
public views on risks and benefits to
produce a majority view that can be
summed up statistically, rather than cre-
ating conditions that allow for disparate
perspectives in the substantive content of
the dialogue.
Our observations and participant feed-
back question whether such conditions
were created in the SCD. In response to
open-ended questions in the evaluation
questionnaire, one participant comment-
ed, ‘‘I suspect the people in the workshop
are not really representative of the popu-
lation as a whole’’, while another was
heard to remark in a break-out group, ‘‘I
don’t feel it is a realistic representation of
how people feel’’. Although the first
comment appears to reflect the kind of
statistical representativeness that we have
queried, it can also be interpreted in
context to mean a concern for the lack of
diversity in societal perspectives articulat-
ed at the workshops.
The sponsors considered the integration
of stakeholder and public voices to be one
of the strengths of the SCD’s methodolo-
gy. In principle, such a framework could
help elicit the implicit ethical assumptions
of scientific and non-scientific positions,
and facilitate open dialogue. Except,
Box 1. Evaluation Methodology
Our evaluation utilised a multi-method approach combining documentary
analysis of project materials and scoping documents commissioned by BBSRC/
MRC, participant questionnaires, structured observation of the workshops, and
semi-structured interviews with seven Oversight Group members (chosen to
represent a cross-section of the group and for their continuous involvement) and
the three lead dialogue facilitators to explore their assessments of the dialogue in
the context of its objectives and of the evaluation criteria. Of 569 questionnaires
distributed at the workshops, 208 were returned, giving a response rate of over
one-third (36.6%). Questionnaires were coded to enable the matching of
responses across the sequence and location of workshops.
Two evaluators observed 11 workshops to cover the range of locations and
sequence of workshops. Detailed observation notes were taken using an
observation protocol adapted from Horlick-Jones et al. [10] that drew attention
to the various activities and outputs and whether these could be considered
successful against the normative evaluation criteria. Observers also recorded their
broader impressions of different aspects of the events. Observer bias was limited
by adherence to the protocol and the comparison of data from workshops
attended by both evaluators. Quantitative data were analysed using SPSS and
qualitative data were analysed in accordance with the evaluation criteria.
The evaluation was constrained in a number of ways. First, the scale of the budget
and the number of person days stipulated by the sponsors precluded a highly
detailed evaluation exercise of the extent that would seem appropriate to the
sponsors’ objectives, especially with regard to longer-term impact. Second, the
evaluators were not consulted on their availability to attend the various
workshops and were thus reliant on the facilitators, in some instances, to
distribute the questionnaires. This meant that we could not be sure that the
purpose, importance, and independence of the evaluation were effectively
communicated. Third, while the evaluation brief specified access to the public
participants for interviews, access was restricted due to the confidentiality/privacy
agreements BMRB had with the participants.
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BMRB used findings from preceding
telephone interviews with 49 stakehold-
ers—broadly categorised as research sci-
entists, clinicians, social scientists, ethicists,
commercial and pharmaceutical organisa-
tions, religious and faith groups, medical
charities, pro-life groups, funders, govern-
ment, and regulators—to structure the
public’s deliberations in the workshops.
Thus, participants were carved out at the
outset into ‘‘stakeholders’’ and the ‘‘pub-
lic’’ and were engaged differently. The
artificial separation of ‘‘stakeholders’’ and
the ‘‘public’’—and the presumption that
the public do not have an equivalent stake
in the technology—meant that diverse
perspectives, visions, and values could
not emerge through the process of dialogue.
Instead, the structure promoted deficit
notions of experts as bearers of purely
‘‘scientific’’ information and the public as
bearers of purely ‘‘value’’ commitments,
creating a hierarchy that hindered genuine
deliberation—in keeping with instrumen-
tal ends, such as acquiring public under-
standing or acceptance.
During the dialogue process, we observed
that minority views were welcomed by the
facilitators, who often took time to explore
why such views were held. In spite of this
encouragement, one participant in Lon-
don, who believed her opinion to be
contrary to other views presented, did
not feel that she had the power or
authority to be heard. Likewise, a Cardiff
participant was reluctant, until repeatedly
pressed by a facilitator, to express her
opinion that human embryonic stem cell
research was morally wrong. Although a
few participants repeatedly interrupted or
challenged the perspectives of others in the
London workshops, disagreements were
rare and generally amicable for such an
ethically complex topic. Such disagree-
ments, when they did occur, often centred
on differing religious convictions or per-
sonal experiences with family members or
friends. Participants seemed satisfied rath-
er than frustrated with the process,
although one or two participants in some
workshops did leave for unknown reasons.
BMRB acknowledged that this was unfor-
tunate, noting that there were some
participants with contrary views in the
first workshops, distinguished along reli-
gious and cultural lines, who had subse-
quently fell silent or dropped out (inter-
view, 16 December 2008).
The homogeneity of responses appears
to have been shaped by the role played by
experts in framing the discussion. Framing
played a significant role in bounding the
discussions as participants showed a strong
tendency to follow and explore the main
issues raised in the experts’ presentations.
We noted significant variations in the
responsiveness of participants to particular
experts who were more effective commu-
nicators. We also observed considerable
homogeneity among the general views and
attitudes of the scientists and clinicians,
save for embryonic stem cell scientists and
adult stem cell scientists. We observed that
the scientists/clinicians were typically in
favour of stem cell science and the
ethicists/social scientists were generally
reluctant to criticise it. There was an
absence of experts willing to discuss the
problems that have already been encoun-
tered with stem cell research and regener-
ative medicine (e.g., the fact that we are
still at the early stages of development for
cell therapies for many diseases) and other
novel therapeutics (e.g., gene therapies,
xenotransplantation) and the potential
problems we are likely to encounter in
the future (e.g., the logistical and proce-
dural difficulties that will be involved in
translating stem cell science into clinical
applications).
The lack of alternative or more critical/
sceptical perspectives of counter-experts
(e.g., advocacy/pro-life group, religious
group, journalistic, or National Health
Service viewpoints) limited the range of
participants’ discussion and increased the
potential for obtaining positively biased
indications of public approval and accep-
tance. Counter-experts were mostly invis-
ible in the public workshops, as they were
defined in terms of religious/faith groups
and pro-life groups and consigned to the
external stakeholder group. Hence, the
SCD can be criticised in the sense that it
did not create conditions for substantive
disagreements or counter perspectives to
emerge in the dialogue process.
Tensions arising from competing ratio-
nales affected the ways in which the
representativeness of the public participants
was variously, and problematically, con-
strued in the design of the SCD. The
sponsors’ aims and objectives, suggesting
normative aspirations, aimed to create an
‘‘improved environment for dialogue be-
tween scientists, science policy makers, other
stakeholders and diverse publics’’ (an antic-
ipated outcome listed in the unpublished
invitation to tender for the evaluation) that,
initially at least, engaged the public as subjects
of the dialogue. However, the SCD meth-
odology limited participants’ opportunities to
introduce alternative frames in the substantive
content of the dialogue, as it was structured
around the predetermined topic guides and
the expert presentations in the workshop. In
this sense it cannot be said that the public
was convincingly engaged as architects (or
framers) of the dialogue. Finally, instrumental
pressures exerted by the broader policy and
research context, and by the artificial
separation (reinforcing deficit conditions for
public acceptance and limiting conditions for
dissent) then integration (to create a seem-
ingly consensual verdict on stem cell re-
search) of public and stakeholder perspec-
tives, suggest a strong possibility that the
public was engaged as objects of the dialogue.
Lessons for Public Engagement
In an earlier Perspective in this series,
Stirling [3] recognises that the way to
achieve a new enlightened democratic
approach is not through procedural design
but in the creation of a ‘‘dynamic new
political arena—in which reasoned scepti-
cism is as valued in public debates about
technology as it is in science itself’’. Yet the
challenges of doing this in practice remain
considerable.
We hypothesised that representativeness
of participation, understood as manifest in
a diversity of perspectives, may not
necessarily confer representativeness on
the outcome. And from a democratic
perspective, an outcome that fails to reflect
a representative range of views on stem
cells renders the SCD a failure. But how
and under what conditions competing
rationales for engagement emerge aren’t
always, if ever, predictable, despite the
best intentions of the organizers or spon-
sors. As a result, plans to mitigate such
occurrences are likely to fail.
Thus, rather than focus on mending the
broken process of PE, we would do better
to focus on why PE is important in a
democratic society. A possible way out of
this democratic dilemma is one in which
the public is principally engaged as the
architect/s (rather than only as the subject or
object) of these dynamic political arenas.
Only in that way can the substantive
conditions for uncertainty, complexity,
and contingency be sustained and
strengthened against the desire for prede-
termined outcomes and institutional pres-
sures. In this sense it is useful to redefine
the purpose of PE, not as a structured
process in which initial conditions are
established through a defined methodolo-
gy that generates desired outcomes, but as
an emergent process in which outcomes—
in form, content, and number—are inher-
ently uncertain, reflecting the indetermi-
nate nature of public interactions. Accord-
ingly, PE motivated by substantive and
normative imperatives, undertaken as one
element of a wider process of technology
assessment, is more likely to fulfil the
democratic ideals of PE.
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